Literature DB >> 33659292

Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors.

Fábio F Rosa1,2,3, Cristiana F Pires1,2,3, Olga Zimmermannova1,2, Carlos-Filipe Pereira1,2,3.   

Abstract

Ectopic expression of transcription factor combinations has been recently demonstrated to reprogram differentiated somatic cells towards the dendritic cell (DC) lineage without reversion to a multipotent state. DCs have the ability to induce potent and long-lasting adaptive immune responses. In particular, conventional type 1 DCs (cDC1s) excel on antigen cross-presentation, a critical step for inducing CD8+ T cell cytotoxic responses. The rarity of naturally occurring cDC1s and lack of in vitro methodologies for the generation of pure cDC1 populations strongly hinders the study of cDC1 lineage specification and function. Here, we describe a protocol for the generation of induced DCs (iDCs) by lentiviral-mediated expression of the transcription factors PU.1, IRF8 and BATF3 in mouse embryonic fibroblasts. iDCs acquire DC morphology, cDC1 phenotype and transcriptional signatures within 9 days. iDCs generated with this protocol acquire functional ability to respond to inflammatory stimuli, engulf dead cells, process and cross-present antigens to CD8+ T cells. DC reprogramming provides a simple and tractable system to generate high numbers of cDC1-like cells for high content screening, opening new avenues to better understand cDC1 specification and function. In the future, faithful induction of cDC1 fate in fibroblasts may lead to the generation of patient-specific DCs for vaccination.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Antigen presenting cell; Cell fate conversion; Cell reprogramming; Dendritic cell; Immunity; Immunotherapy; Mouse embryonic fibroblast; Transcription factor

Year:  2020        PMID: 33659292      PMCID: PMC7842401          DOI: 10.21769/BioProtoc.3619

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  30 in total

1.  Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.

Authors:  Fábio F Rosa; Cristiana F Pires; Ilia Kurochkin; Alexandra G Ferreira; Andreia M Gomes; Luís G Palma; Kritika Shaiv; Laura Solanas; Cláudia Azenha; Dmitri Papatsenko; Oliver Schulz; Caetano Reis e Sousa; Carlos-Filipe Pereira
Journal:  Sci Immunol       Date:  2018-12-07

Review 2.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

3.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

4.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.

Authors:  Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

5.  The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin.

Authors:  A I Proietto; D Mittag; A W Roberts; N Sprigg; L Wu
Journal:  Cell Mol Immunol       Date:  2012-10-22       Impact factor: 11.530

6.  Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.

Authors:  Satoru Senju; Miwa Haruta; Yusuke Matsunaga; Satoshi Fukushima; Tokunori Ikeda; Kazutoshi Takahashi; Keisuke Okita; Shinya Yamanaka; Yasuharu Nishimura
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

7.  ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Sestili; Paola Borghi; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

8.  Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells.

Authors:  Margaret E Kirkling; Urszula Cytlak; Colleen M Lau; Kanako L Lewis; Anastasia Resteu; Alireza Khodadadi-Jamayran; Christian W Siebel; Hélène Salmon; Miriam Merad; Aristotelis Tsirigos; Matthew Collin; Venetia Bigley; Boris Reizis
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

Review 9.  Understanding and Modulating Immunity With Cell Reprogramming.

Authors:  Cristiana F Pires; Fábio F Rosa; Ilia Kurochkin; Carlos-Filipe Pereira
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Progress in the Application of Drugs for the Treatment of Multiple Sclerosis.

Authors:  Weipeng Wei; Denglei Ma; Lin Li; Lan Zhang
Journal:  Front Pharmacol       Date:  2021-07-13       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.